Cancer Diagnostic Devices-North America Market Status and Trend Report 2013-2023

January 2018 | 157 pages | ID: C0A29EDAAA2EN
MIReports Co., Limited

Abstracts

Report Summary

Cancer Diagnostic Devices-North America Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Cancer Diagnostic Devices industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

• Whole North America and Regional Market Size of Cancer Diagnostic Devices 2013-2017, and development forecast 2018-2023
• Main market players of Cancer Diagnostic Devices in North America, with company and product introduction, position in the Cancer Diagnostic Devices market
• Market status and development trend of Cancer Diagnostic Devices by types and applications
• Cost and profit status of Cancer Diagnostic Devices, and marketing status
• Market growth drivers and challenges

The report segments the North America Cancer Diagnostic Devices market as:

North America Cancer Diagnostic Devices Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
United States
Canada
Mexico

North America Cancer Diagnostic Devices Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Genomics
Proteomics
Metabolomics
Epigenetics

North America Cancer Diagnostic Devices Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Diagnostic
Personalized Medicine
Research

North America Cancer Diagnostic Devices Market: Players Segment Analysis (Company and Product introduction, Cancer Diagnostic Devices Sales Volume, Revenue, Price and Gross Margin):
Agilent Technologies, Inc. (U.S.)
Thermo Fisher Scientific, Inc. (U.S.)
Illumina, Inc. (Denmark)
Becton, Dickinson and Company (U.S.)
GE Healthcare (U.K.)
QIAGEN N.V. (Netherlands)
Abbott Laboratories, Inc. (U.S.)
Roche Diagnostics (Switzerland)
Siemens Healthcare (Germany)
Philips Healthcare (U.K.)
C.R. Bard, Inc. (U.S.)

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.

Contents

CHAPTER 1 OVERVIEW OF CANCER DIAGNOSTIC DEVICES

1.1 Definition of Cancer Diagnostic Devices in This Report
1.2 Commercial Types of Cancer Diagnostic Devices
  1.2.1 Genomics
  1.2.2 Proteomics
  1.2.3 Metabolomics
  1.2.4 Epigenetics
1.3 Downstream Application of Cancer Diagnostic Devices
  1.3.1 Diagnostic
  1.3.2 Personalized Medicine
  1.3.3 Research
1.4 Development History of Cancer Diagnostic Devices
1.5 Market Status and Trend of Cancer Diagnostic Devices 2013-2023
  1.5.1 North America Cancer Diagnostic Devices Market Status and Trend 2013-2023
  1.5.2 Regional Cancer Diagnostic Devices Market Status and Trend 2013-2023

CHAPTER 2 NORTH AMERICA MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Cancer Diagnostic Devices in North America 2013-2017
2.2 Consumption Market of Cancer Diagnostic Devices in North America by Regions
  2.2.1 Consumption Volume of Cancer Diagnostic Devices in North America by Regions
  2.2.2 Revenue of Cancer Diagnostic Devices in North America by Regions
2.3 Market Analysis of Cancer Diagnostic Devices in North America by Regions
  2.3.1 Market Analysis of Cancer Diagnostic Devices in United States 2013-2017
  2.3.2 Market Analysis of Cancer Diagnostic Devices in Canada 2013-2017
  2.3.3 Market Analysis of Cancer Diagnostic Devices in Mexico 2013-2017
2.4 Market Development Forecast of Cancer Diagnostic Devices in North America 2018-2023
  2.4.1 Market Development Forecast of Cancer Diagnostic Devices in North America 2018-2023
  2.4.2 Market Development Forecast of Cancer Diagnostic Devices by Regions 2018-2023

CHAPTER 3 NORTH AMERICA MARKET STATUS AND FORECAST BY TYPES

3.1 Whole North America Market Status by Types
  3.1.1 Consumption Volume of Cancer Diagnostic Devices in North America by Types
  3.1.2 Revenue of Cancer Diagnostic Devices in North America by Types
3.2 North America Market Status by Types in Major Countries
  3.2.1 Market Status by Types in United States
  3.2.2 Market Status by Types in Canada
  3.2.3 Market Status by Types in Mexico
3.3 Market Forecast of Cancer Diagnostic Devices in North America by Types

CHAPTER 4 NORTH AMERICA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Cancer Diagnostic Devices in North America by Downstream Industry
4.2 Demand Volume of Cancer Diagnostic Devices by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Cancer Diagnostic Devices by Downstream Industry in United States
  4.2.2 Demand Volume of Cancer Diagnostic Devices by Downstream Industry in Canada
  4.2.3 Demand Volume of Cancer Diagnostic Devices by Downstream Industry in Mexico
4.3 Market Forecast of Cancer Diagnostic Devices in North America by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF CANCER DIAGNOSTIC DEVICES

5.1 North America Economy Situation and Trend Overview
5.2 Cancer Diagnostic Devices Downstream Industry Situation and Trend Overview

CHAPTER 6 CANCER DIAGNOSTIC DEVICES MARKET COMPETITION STATUS BY MAJOR PLAYERS IN NORTH AMERICA

6.1 Sales Volume of Cancer Diagnostic Devices in North America by Major Players
6.2 Revenue of Cancer Diagnostic Devices in North America by Major Players
6.3 Basic Information of Cancer Diagnostic Devices by Major Players
  6.3.1 Headquarters Location and Established Time of Cancer Diagnostic Devices Major Players
  6.3.2 Employees and Revenue Level of Cancer Diagnostic Devices Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 CANCER DIAGNOSTIC DEVICES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Agilent Technologies, Inc. (U.S.)
  7.1.1 Company profile
  7.1.2 Representative Cancer Diagnostic Devices Product
  7.1.3 Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin of Agilent Technologies, Inc. (U.S.)
7.2 Thermo Fisher Scientific, Inc. (U.S.)
  7.2.1 Company profile
  7.2.2 Representative Cancer Diagnostic Devices Product
  7.2.3 Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific, Inc. (U.S.)
7.3 Illumina, Inc. (Denmark)
  7.3.1 Company profile
  7.3.2 Representative Cancer Diagnostic Devices Product
  7.3.3 Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin of Illumina, Inc. (Denmark)
7.4 Becton, Dickinson and Company (U.S.)
  7.4.1 Company profile
  7.4.2 Representative Cancer Diagnostic Devices Product
  7.4.3 Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin of Becton, Dickinson and Company (U.S.)
7.5 GE Healthcare (U.K.)
  7.5.1 Company profile
  7.5.2 Representative Cancer Diagnostic Devices Product
  7.5.3 Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin of GE Healthcare (U.K.)
7.6 QIAGEN N.V. (Netherlands)
  7.6.1 Company profile
  7.6.2 Representative Cancer Diagnostic Devices Product
  7.6.3 Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin of QIAGEN N.V. (Netherlands)
7.7 Abbott Laboratories, Inc. (U.S.)
  7.7.1 Company profile
  7.7.2 Representative Cancer Diagnostic Devices Product
  7.7.3 Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin of Abbott Laboratories, Inc. (U.S.)
7.8 Roche Diagnostics (Switzerland)
  7.8.1 Company profile
  7.8.2 Representative Cancer Diagnostic Devices Product
  7.8.3 Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin of Roche Diagnostics (Switzerland)
7.9 Siemens Healthcare (Germany)
  7.9.1 Company profile
  7.9.2 Representative Cancer Diagnostic Devices Product
  7.9.3 Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin of Siemens Healthcare (Germany)
7.10 Philips Healthcare (U.K.)
  7.10.1 Company profile
  7.10.2 Representative Cancer Diagnostic Devices Product
  7.10.3 Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin of Philips Healthcare (U.K.)
7.11 C.R. Bard, Inc. (U.S.)
  7.11.1 Company profile
  7.11.2 Representative Cancer Diagnostic Devices Product
  7.11.3 Cancer Diagnostic Devices Sales, Revenue, Price and Gross Margin of C.R. Bard, Inc. (U.S.)

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF CANCER DIAGNOSTIC DEVICES

8.1 Industry Chain of Cancer Diagnostic Devices
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF CANCER DIAGNOSTIC DEVICES

9.1 Cost Structure Analysis of Cancer Diagnostic Devices
9.2 Raw Materials Cost Analysis of Cancer Diagnostic Devices
9.3 Labor Cost Analysis of Cancer Diagnostic Devices
9.4 Manufacturing Expenses Analysis of Cancer Diagnostic Devices

CHAPTER 10 MARKETING STATUS ANALYSIS OF CANCER DIAGNOSTIC DEVICES

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference